Last reviewed · How we verify
THDB0206 injection
THDB0206 injection's mechanism is not publicly available.
At a glance
| Generic name | THDB0206 injection |
|---|---|
| Sponsor | Tonghua Dongbao Pharmaceutical Co.,Ltd |
| Modality | Small molecule |
| Phase | Phase 3 |
Mechanism of action
Due to the lack of publicly available information, a detailed explanation of its mechanism cannot be provided.
Approved indications
Common side effects
Key clinical trials
- Efficacy and Safety of THDB0206 Compared to Insulin Lispro Injection in Participants With Type 2 Diabetes (PHASE3)
- Efficacy and Safety of THDB0206 Compared to Insulin Lispro Injection in Participants With Type 1 Diabetes (PHASE3)
- Comparative PK/PD of Single-Dose THDB0206 at Different Injection Sites (PHASE1)
- A Trial to Evaluate the Pharmacokinetics and Pharmacodynamics of THDB0206 Injection in Healthy Chinese Subjects (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |